Global Enteral Feeding Formulas Market to Reach $7.8 Billion by 2030
The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.
New York, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Enteral Feeding Formulas Industry" - https://www.reportlinker.com/p05798511/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Global Enteral Feeding Formulas Market to Reach $7.8 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Enteral Feeding Formulas estimated at US$6 Billion in the year 2022, is projected to reach a revised size of US$7.8 Billion by 2030, growing at aCAGR of 3.3% over the period 2022-2030. Standard Formula, one of the segments analyzed in the report, is projected to record 2.4% CAGR and reach US$3.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Disease-Specific Formulas segment is readjusted to a revised 4.4% CAGR for the next 8-year period.
The U.S. Market is Estimated at $1.6 Billion, While China is Forecast to Grow at 5.7% CAGR
The Enteral Feeding Formulas market in the U.S. is estimated at US$1.6 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 5.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.8% and 4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 1.6% CAGR.
Select Competitors (Total 46 Featured)
- Abbott Laboratories
- B. Braun Melsungen AG
- Danone SA
- Fresenius Kabi AG
- Global Health Products, Inc.
- Hormel Foods Corporation
- Mead Johnson Nutrition Company
- Meiji Holdings Co., Ltd.
- Nestec, Inc.
- Victus, Inc.
Read the full report: https://www.reportlinker.com/p05798511/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Enteral Feeding Formulas Market to Witness Steady Gains
Rapid Growth in Ageing Population to Drive Market Growth
Global Population Statistics and Estimates for the 60+ Age
Group (1990, 2015, 2050E, 2100E)
Enteral Feeding Formulas - Global Key Competitors Percentage
Market Share in 2023 (E)
Increase in Healthcare Spending Across the Globe to Bolster
Market Growth
Health Care and GDP Per Capita Spending in USD: 2017
Percentage of Healthcare Spending by Expenditure Type: 2017
Growth Rates of Healthcare Spending by Spending Type: 2008-20017
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2023 (E)
Growing Incidence of Chronic Diseases to Bolster Enteral
Feeding Formulas Market
Total Number of People Suffering from Chronic Ailments in the
US: 1996-2030
Preterm Births: Another Contributing Factor for Market Growth
Growth in Homecare Demand to Bolster Market Growth
With Higher Need for Personalized Medicines, the Market to
Register Substantial Gains
Total Availability of Personalized Medicines in the US: 2008-2016
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Enteral Feeding Formulas by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2022 through 2030 and % CAGR
Table 2: World Historic Review for Enteral Feeding Formulas by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 3: World 16-Year Perspective for Enteral Feeding Formulas
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2014, 2023 & 2030
Table 4: World Recent Past, Current & Future Analysis for
Hospitals by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 5: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 6: World 16-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030
Table 7: World Recent Past, Current & Future Analysis for Home
Care by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR
Table 8: World Historic Review for Home Care by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 9: World 16-Year Perspective for Home Care by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030
Table 10: World Enteral Feeding Formulas Market Analysis of
Annual Sales in US$ Million for Years 2014 through 2030
Table 11: World Recent Past, Current & Future Analysis for
Critical Care by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 12: World Historic Review for Critical Care by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 13: World 16-Year Perspective for Critical Care by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 14: World Recent Past, Current & Future Analysis for
Neurology by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 15: World Historic Review for Neurology by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 16: World 16-Year Perspective for Neurology by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030
Table 17: World Recent Past, Current & Future Analysis for
Standard Formula by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR
Table 18: World Historic Review for Standard Formula by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 19: World 16-Year Perspective for Standard Formula by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 20: World Recent Past, Current & Future Analysis for
Disease-Specific Formulas by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2022 through 2030 and % CAGR
Table 21: World Historic Review for Disease-Specific Formulas
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 22: World 16-Year Perspective for Disease-Specific
Formulas by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2014, 2023 &
2030
Table 23: World Recent Past, Current & Future Analysis for
Adult by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR
Table 24: World Historic Review for Adult by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 25: World 16-Year Perspective for Adult by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030
Table 26: World Recent Past, Current & Future Analysis for
Pediatric by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 27: World Historic Review for Pediatric by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 28: World 16-Year Perspective for Pediatric by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030
Table 29: World Recent Past, Current & Future Analysis for
Oncology by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 30: World Historic Review for Oncology by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 31: World 16-Year Perspective for Oncology by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030
Table 32: World Recent Past, Current & Future Analysis for
Gastroenterology by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR
Table 33: World Historic Review for Gastroenterology by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 34: World 16-Year Perspective for Gastroenterology by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 35: World Recent Past, Current & Future Analysis for
Diabetes by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 36: World Historic Review for Diabetes by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 37: World 16-Year Perspective for Diabetes by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030
Table 38: World Recent Past, Current & Future Analysis for
Other Applications by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR
Table 39: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 40: World 16-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
III. MARKET ANALYSIS
UNITED STATES
Enteral Feeding Formulas Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United States for 2023 (E)
Table 41: USA Recent Past, Current & Future Analysis for
Enteral Feeding Formulas by Product - Standard Formula and
Disease-Specific Formulas - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 42: USA Historic Review for Enteral Feeding Formulas by
Product - Standard Formula and Disease-Specific Formulas
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 43: USA 16-Year Perspective for Enteral Feeding Formulas
by Product - Percentage Breakdown of Value Sales for Standard
Formula and Disease-Specific Formulas for the Years 2014, 2023 &
2030
Table 44: USA Recent Past, Current & Future Analysis for
Enteral Feeding Formulas by Application - Oncology,
Gastroenterology, Critical Care, Neurology, Diabetes and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 45: USA Historic Review for Enteral Feeding Formulas by
Application - Oncology, Gastroenterology, Critical Care,
Neurology, Diabetes and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 46: USA 16-Year Perspective for Enteral Feeding Formulas
by Application - Percentage Breakdown of Value Sales for
Oncology, Gastroenterology, Critical Care, Neurology, Diabetes
and Other Applications for the Years 2014, 2023 & 2030
Table 47: USA Recent Past, Current & Future Analysis for
Enteral Feeding Formulas by End-Use - Home Care and Hospitals -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 48: USA Historic Review for Enteral Feeding Formulas by
End-Use - Home Care and Hospitals Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 49: USA 16-Year Perspective for Enteral Feeding Formulas
by End-Use - Percentage Breakdown of Value Sales for Home Care
and Hospitals for the Years 2014, 2023 & 2030
Table 50: USA Recent Past, Current & Future Analysis for
Enteral Feeding Formulas by Stage - Adult and Pediatric -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 51: USA Historic Review for Enteral Feeding Formulas by
Stage - Adult and Pediatric Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR
Table 52: USA 16-Year Perspective for Enteral Feeding Formulas
by Stage - Percentage Breakdown of Value Sales for Adult and
Pediatric for the Years 2014, 2023 & 2030
CANADA
Table 53: Canada Recent Past, Current & Future Analysis for
Enteral Feeding Formulas by Product - Standard Formula and
Disease-Specific Formulas - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 54: Canada Historic Review for Enteral Feeding Formulas
by Product - Standard Formula and Disease-Specific Formulas
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 55: Canada 16-Year Perspective for Enteral Feeding
Formulas by Product - Percentage Breakdown of Value Sales for
Standard Formula and Disease-Specific Formulas for the Years
2014, 2023 & 2030
Table 56: Canada Recent Past, Current & Future Analysis for
Enteral Feeding Formulas by Application - Oncology,
Gastroenterology, Critical Care, Neurology, Diabetes and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 57: Canada Historic Review for Enteral Feeding Formulas
by Application - Oncology, Gastroenterology, Critical Care,
Neurology, Diabetes and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 58: Canada 16-Year Perspective for Enteral Feeding
Formulas by Application - Percentage Breakdown of Value Sales
for Oncology, Gastroenterology, Critical Care, Neurology,
Diabetes and Other Applications for the Years 2014, 2023 & 2030
Table 59: Canada Recent Past, Current & Future Analysis for
Enteral Feeding Formulas by End-Use - Home Care and Hospitals -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 60: Canada Historic Review for Enteral Feeding Formulas
by End-Use - Home Care and Hospitals Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 61: Canada 16-Year Perspective for Enteral Feeding
Formulas by End-Use - Percentage Breakdown of Value Sales for
Home Care and Hospitals for the Years 2014, 2023 & 2030
Table 62: Canada Recent Past, Current & Future Analysis for
Enteral Feeding Formulas by Stage - Adult and Pediatric -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 63: Canada Historic Review for Enteral Feeding Formulas
by Stage - Adult and Pediatric Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 64: Canada 16-Year Perspective for Enteral Feeding
Formulas by Stage - Percentage Breakdown of Value Sales for
Adult and Pediatric for the Years 2014, 2023 & 2030
JAPAN
Enteral Feeding Formulas Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Japan for 2023 (E)
Table 65: Japan Recent Past, Current & Future Analysis for
Enteral Feeding Formulas by Product - Standard Formula and
Disease-Specific Formulas - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 66: Japan Historic Review for Enteral Feeding Formulas by
Product - Standard Formula and Disease-Specific Formulas
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 67: Japan 16-Year Perspective for Enteral Feeding
Formulas by Product - Percentage Breakdown of Value Sales for
Standard Formula and Disease-Specific Formulas for the Years
2014, 2023 & 2030
Table 68: Japan Recent Past, Current & Future Analysis for
Enteral Feeding Formulas by Application - Oncology,
Gastroenterology, Critical Care, Neurology, Diabetes and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 69: Japan Historic Review for Enteral Feeding Formulas by
Application - Oncology, Gastroenterology, Critical Care,
Neurology, Diabetes and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 70: Japan 16-Year Perspective for Enteral Feeding
Formulas by Application - Percentage Breakdown of Value Sales
for Oncology, Gastroenterology, Critical Care, Neurology,
Diabetes and Other Applications for the Years 2014, 2023 & 2030
Table 71: Japan Recent Past, Current & Future Analysis for
Enteral Feeding Formulas by End-Use - Home Care and Hospitals -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 72: Japan Historic Review for Enteral Feeding Formulas by
End-Use - Home Care and Hospitals Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 73: Japan 16-Year Perspective for Enteral Feeding
Formulas by End-Use - Percentage Breakdown of Value Sales for
Home Care and Hospitals for the Years 2014, 2023 & 2030
Table 74: Japan Recent Past, Current & Future Analysis for
Enteral Feeding Formulas by Stage - Adult and Pediatric -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 75: Japan Historic Review for Enteral Feeding Formulas by
Stage - Adult and Pediatric Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR
Table 76: Japan 16-Year Perspective for Enteral Feeding
Formulas by Stage - Percentage Breakdown of Value Sales for
Adult and Pediatric for the Years 2014, 2023 & 2030
CHINA
Enteral Feeding Formulas Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in China for 2023 (E)
Table 77: China Recent Past, Current & Future Analysis for
Enteral Feeding Formulas by Product - Standard Formula and
Disease-Specific Formulas - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 78: China Historic Review for Enteral Feeding Formulas by
Product - Standard Formula and Disease-Specific Formulas
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 79: China 16-Year Perspective for Enteral Feeding
Formulas by Product - Percentage Breakdown of Value Sales for
Standard Formula and Disease-Specific Formulas for the Years
2014, 2023 & 2030
Table 80: China Recent Past, Current & Future Analysis for
Enteral Feeding Formulas by Application - Oncology,
Gastroenterology, Critical Care, Neurology, Diabetes and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 81: China Historic Review for Enteral Feeding Formulas by
Application - Oncology, Gastroenterology, Critical Care,
Neurology, Diabetes and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 82: China 16-Year Perspective for Enteral Feeding
Formulas by Application - Percentage Breakdown of Value Sales
for Oncology, Gastroenterology, Critical Care, Neurology,
Diabetes and Other Applications for the Years 2014, 2023 & 2030
Table 83: China Recent Past, Current & Future Analysis for
Enteral Feeding Formulas by End-Use - Home Care and Hospitals -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 84: China Historic Review for Enteral Feeding Formulas by
End-Use - Home Care and Hospitals Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 85: China 16-Year Perspective for Enteral Feeding
Formulas by End-Use - Percentage Breakdown of Value Sales for
Home Care and Hospitals for the Years 2014, 2023 & 2030
Table 86: China Recent Past, Current & Future Analysis for
Enteral Feeding Formulas by Stage - Adult and Pediatric -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 87: China Historic Review for Enteral Feeding Formulas by
Stage - Adult and Pediatric Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR
Table 88: China 16-Year Perspective for Enteral Feeding
Formulas by Stage - Percentage Breakdown of Value Sales for
Adult and Pediatric for the Years 2014, 2023 & 2030
EUROPE
Enteral Feeding Formulas Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Europe for 2023 (E)
Table 89: Europe Recent Past, Current & Future Analysis for
Enteral Feeding Formulas by Geographic Region - France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR
Table 90: Europe Historic Review for Enteral Feeding Formulas
by Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR
Table 91: Europe 16-Year Perspective for Enteral Feeding
Formulas by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets for Years 2014, 2023 & 2030
Table 92: Europe Recent Past, Current & Future Analysis for
Enteral Feeding Formulas by Product - Standard Formula and
Disease-Specific Formulas - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 93: Europe Historic Review for Enteral Feeding Formulas
by Product - Standard Formula and Disease-Specific Formulas
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 94: Europe 16-Year Perspective for Enteral Feeding
Formulas by Product - Percentage Breakdown of Value Sales for
Standard Formula and Disease-Specific Formulas for the Years
2014, 2023 & 2030
Table 95: Europe Recent Past, Current & Future Analysis for
Enteral Feeding Formulas by Application - Oncology,
Gastroenterology, Critical Care, Neurology, Diabetes and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 96: Europe Historic Review for Enteral Feeding Formulas
by Application - Oncology, Gastroenterology, Critical Care,
Neurology, Diabetes and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 97: Europe 16-Year Perspective for Enteral Feeding
Formulas by Application - Percentage Breakdown of Value Sales
for Oncology, Gastroenterology, Critical Care, Neurology,
Diabetes and Other Applications for the Years 2014, 2023 & 2030
Table 98: Europe Recent Past, Current & Future Analysis for
Enteral Feeding Formulas by End-Use - Home Care and Hospitals -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 99: Europe Historic Review for Enteral Feeding Formulas
by End-Use - Home Care and Hospitals Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 100: Europe 16-Year Perspective for Enteral Feeding
Formulas by End-Use - Percentage Breakdown of Value Sales for
Home Care and Hospitals for the Years 2014, 2023 & 2030
Table 101: Europe Recent Past, Current & Future Analysis for
Enteral Feeding Formulas by Stage - Adult and Pediatric -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 102: Europe Historic Review for Enteral Feeding Formulas
by Stage - Adult and Pediatric Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 103: Europe 16-Year Perspective for Enteral Feeding
Formulas by Stage - Percentage Breakdown of Value Sales for
Adult and Pediatric for the Years 2014, 2023 & 2030
FRANCE
Enteral Feeding Formulas Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in France for 2023 (E)
Table 104: France Recent Past, Current & Future Analysis for
Enteral Feeding Formulas by Product - Standard Formula and
Disease-Specific Formulas - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 105: France Historic Review for Enteral Feeding Formulas
by Product - Standard Formula and Disease-Specific Formulas
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 106: France 16-Year Perspective for Enteral Feeding
Formulas by Product - Percentage Breakdown of Value Sales for
Standard Formula and Disease-Specific Formulas for the Years
2014, 2023 & 2030
Table 107: France Recent Past, Current & Future Analysis for
Enteral Feeding Formulas by Application - Oncology,
Gastroenterology, Critical Care, Neurology, Diabetes and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 108: France Historic Review for Enteral Feeding Formulas
by Application - Oncology, Gastroenterology, Critical Care,
Neurology, Diabetes and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 109: France 16-Year Perspective for Enteral Feeding
Formulas by Application - Percentage Breakdown of Value Sales
for Oncology, Gastroenterology, Critical Care, Neurology,
Diabetes and Other Applications for the Years 2014, 2023 & 2030
Table 110: France Recent Past, Current & Future Analysis for
Enteral Feeding Formulas by End-Use - Home Care and Hospitals -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 111: France Historic Review for Enteral Feeding Formulas
by End-Use - Home Care and Hospitals Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 112: France 16-Year Perspective for Enteral Feeding
Formulas by End-Use - Percentage Breakdown of Value Sales for
Home Care and Hospitals for the Years 2014, 2023 & 2030
Table 113: France Recent Past, Current & Future Analysis for
Enteral Feeding Formulas by Stage - Adult and Pediatric -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 114: France Historic Review for Enteral Feeding Formulas
by Stage - Adult and Pediatric Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 115: France 16-Year Perspective for Enteral Feeding
Formulas by Stage - Percentage Breakdown of Value Sales for
Adult and Pediatric for the Years 2014, 2023 & 2030
GERMANY
Enteral Feeding Formulas Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Germany for 2023 (E)
Table 116: Germany Recent Past, Current & Future Analysis for
Enteral Feeding Formulas by Product - Standard Formula and
Disease-Specific Formulas - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 117: Germany Historic Review for Enteral Feeding Formulas
by Product - Standard Formula and Disease-Specific Formulas
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 118: Germany 16-Year Perspective for Enteral Feeding
Formulas by Product - Percentage Breakdown of Value Sales for
Standard Formula and Disease-Specific Formulas for the Years
2014, 2023 & 2030
Table 119: Germany Recent Past, Current & Future Analysis for
Enteral Feeding Formulas by Application - Oncology,
Gastroenterology, Critical Care, Neurology, Diabetes and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 120: Germany Historic Review for Enteral Feeding Formulas
by Application - Oncology, Gastroenterology, Critical Care,
Neurology, Diabetes and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 121: Germany 16-Year Perspective for Enteral Feeding
Formulas by Application - Percentage Breakdown of Value Sales
for Oncology, Gastroenterology, Critical Care, Neurology,
Diabetes and Other Applications for the Years 2014, 2023 & 2030
Table 122: Germany Recent Past, Current & Future Analysis for
Enteral Feeding Formulas by End-Use - Home Care and Hospitals -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 123: Germany Historic Review for Enteral Feeding Formulas
by End-Use - Home Care and Hospitals Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 124: Germany 16-Year Perspective for Enteral Feeding
Formulas by End-Use - Percentage Breakdown of Value Sales for
Home Care and Hospitals for the Years 2014, 2023 & 2030
Table 125: Germany Recent Past, Current & Future Analysis for
Enteral Feeding Formulas by Stage - Adult and Pediatric -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 126: Germany Historic Review for Enteral Feeding Formulas
by Stage - Adult and Pediatric Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 127: Germany 16-Year Perspective for Enteral Feeding
Formulas by Stage - Percentage Breakdown of Value Sales for
Adult and Pediatric for the Years 2014, 2023 & 2030
ITALY
Table 128: Italy Recent Past, Current & Future Analysis for
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05798511/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
